Read Atherton Research Principal Analyst Jean Baptiste Su’s overview of the Pioneers’18 conference that he’s attending this week in Vienna, Austria, which is Europe’s largest entrepreneurship event exclusively focused on early-stage Startups and investing, and future technology trends.
from Forbes – Tech https://ift.tt/2s0hRuP
via IFTTT
A chance lab discovery is opening up the possibility for wide-scale improvements in drug screening, application of selective painkillers, and selectively nuking cancer cells. The mystery material? Graphene, a semi-metal that's composed of a single la…